Cooper Companies (COO) Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" COO shares.
View COO analyst ratings or view top-rated stocks.

8 Wall Street analysts have issued 12-month target prices for Cooper Companies' stock. Their COO share price forecasts range from $295.00 to $460.00. On average, they expect the company's share price to reach $398.80 in the next year. This suggests a possible upside of 8.0% from the stock's current price.
View analysts price targets for COO or view top-rated stocks among Wall Street analysts.

Cooper Companies' stock was trading at $330.67 at the beginning of the year. Since then, COO stock has increased by 11.7% and is now trading at $369.39.
View the best growth stocks for 2023 here.

Cooper Companies saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 1,200,000 shares, a drop of 8.4% from the April 30th total of 1,310,000 shares. Based on an average trading volume of 291,200 shares, the short-interest ratio is currently 4.1 days. Approximately 2.4% of the shares of the company are short sold.
View Cooper Companies' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 1st 2023.
View our COO earnings forecast.

Cooper Companies will be holding an earnings conference call on Thursday, June 1st at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

The Cooper Companies, Inc. (NYSE:COO) released its quarterly earnings results on Thursday, March, 2nd. The medical device company reported $2.90 earnings per share for the quarter, topping analysts' consensus estimates of $2.66 by $0.24. The medical device company had revenue of $858.50 million for the quarter, compared to the consensus estimate of $834.90 million. Cooper Companies had a trailing twelve-month return on equity of 8.39% and a net margin of 11.10%. The company's revenue was up 9.1% on a year-over-year basis. During the same period in the prior year, the firm earned $3.24 EPS.
Read the conference call transcript.

Cooper Companies announced a Semi-Annual dividend on Wednesday, December 14th. Shareholders of record on Monday, January 23rd will be paid a dividend of $0.03 per share on Friday, February 10th. The ex-dividend date is Friday, January 20th.
Read our dividend analysis for COO.

ETFs with the largest weight of Cooper Companies (NYSE:COO) stock in their portfolio include Motley Fool Mid-Cap Growth ETF (TMFM), Goldman Sachs Future Health Care Equity ETF (GDOC), First Trust Indxx Medical Devices ETF (MDEV), Nuveen ESG Mid-Cap Growth ETF (NUMG), BNY Mellon Sustainable US Equity ETF (BKUS), BlackRock Future Health ETF (BMED), Putnam Sustainable Future ETF (PFUT) and Harbor Health Care ETF (MEDI).

Cooper Companies (NYSE:COO) pays an annual dividend of $0.06 per share and currently has a dividend yield of 0.02%. The dividend payout ratio is 0.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, COO will have a dividend payout ratio of 0.42% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for COO.

Cooper Companies issued an update on its FY 2023 earnings guidance on Thursday, March, 2nd. The company provided EPS guidance of $12.60-$12.90 for the period, compared to the consensus earnings per share estimate of $12.52. The company issued revenue guidance of $3.50 billion-$3.55 billion, compared to the consensus revenue estimate of $3.50 billion.

8 employees have rated Cooper Companies Chief Executive Officer Robert S. Weiss on Glassdoor.com. Robert S. Weiss has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cooper Companies investors own include Boeing (BA), AbbVie (ABBV), NVIDIA (NVDA), Netflix (NFLX), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Intel (INTC), Alibaba Group (BABA), Intuitive Surgical (ISRG) and Mastercard (MA).

Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

Cooper Companies' stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.54%), Veritas Asset Management LLP (4.22%), State Street Corp (4.20%), Generation Investment Management LLP (3.29%), Kayne Anderson Rudnick Investment Management LLC (3.10%) and Bank of New York Mellon Corp (2.94%). Insiders that own company stock include Agostino Ricupati, Albert G White III, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Gerard H Warner III, Holly R Sheffield, Jody S Lindell, Robert D Auerbach and Robert S Weiss.
View institutional ownership trends.

Shares of COO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of COO stock can currently be purchased for approximately $369.39.

Cooper Companies (NYSE:COO) has a market capitalization of $18.27 billion and generates $3.31 billion in revenue each year. The medical device company earns $385.80 million in net income (profit) each year or $7.55 on an earnings per share basis.

The company employs 14,000 workers across the globe.

Cooper Companies' mailing address is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. The official website for the company is www.coopercos.com. The medical device company can be reached via phone at (925) 460-3600, via email at ir@cooperco.com, or via fax at 925-460-3649.